newsfilter
← Latest News
PR Newswire·

Abbott initiates pivotal trial for Cephea™ device, an innovative treatment for mitral heart valve disease

CROWN-MV trial will evaluate the safety and effectiveness of investigational Cephea mitral valve replacement deviceAbbott's Cephea is designed to provide a new, minimally invasive option for treating mitral valve